rofl.
Your turtle guru is ahem, more then optimistic.
Forget COVID-19 - RemL is too expensive.
So what's left? Hey what about GI bleeds in LVAD...there was certainly some management excitement about that secondary endpoint "success".
The investment case FOR Mesoblast, page-411
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.160(11.9%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $19.25M | 13.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 26594 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 13204 | 7 |
View Market Depth
| Last trade - 14.39pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |